Chemotherapy-induced peripheral neuropathy. Drug-induced polyneuropathy
Conditions
Interventions
Intervention 1: Intervention group: Topical use of Citrullus colocynthis fruit oil product, twice daily (morning and night), all four lower and upper extremities, from ankle to toe, and from wrist to
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with cancer who have symptoms of peripheral neuropathy The duration between the patient's visit for enrolling to the study and the last time receiving chemotherapy is at most two month A neurologist will recognize that their neuropathy is due to chemotherapy Age between 18-80 years old
Exclusion criteria
Exclusion criteria: Patients with diabetes mellitus Patients with brain metastasis Patients with carpal tunnel syndrome Unwilling to participate in the study Creating acute psychological symptoms such as depression (such as taking medication) Deficiency or high levels of vitamin B6 (according to your doctor's interview and examination) Any positive history of allergic reaction or complications due to uising Citrullus colocynthis Patients with serious illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemotherapy Induced Peripheral Neuropathy score. Timepoint: Before and after. Method of measurement: Using of Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT).;Symptoms and concerns associated specifically with chemotherapy-induced neuropathy score. Timepoint: Before and after. Method of measurement: Using Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ghazaleh Heydarirad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed